Scientists can identify the origins of diseases by studying how RNA turns genes on and off, potentially leading to innovative disease treatments and possible cures.
The RNA Institute offers unique opportunities to researchers and trainees for collaboration and interdisciplinary research. We have more than 50 faculty working to understand the role of RNA in fundamental biological processes, developing RNA as a tool for science and harnessing this knowledge to improve human health.
The RNA Institute is more than just a modern research facility. We are a collection of diverse and talented researchers and laboratories united by a common goal in understanding the role of RNA across different fields, including biology, chemistry, biomedical sciences, physics, and nanobiosciences. RNA forms the basis of our research, it is the common element that we study, build, modify and analyze as well as the building blocks that we use to construct tools, reporters, and therapies.
The RNA Institute News
SUNY Poly and UAlbany Receive $459,000 Award from the National Cancer Institute to Research How Lack of a Key Nutrient Promotes Aging and Cancer
Research enables hands-on learning opportunities for undergraduate and graduate students
Noteworthy: Research grants, awards and publications
September, 2022, notifications of UAlbany faculty awards and publications
Lecture Discusses mRNA Breakthroughs, Challenges
The challenges and breakthroughs associated with mRNA technologies will be discussed in the latest "Life at the Interface of Science+Engineering Lecture Series" event on Thursday, Sept. 15.
Podcast: The Research Behind Myotonic Dystrophy
Dr. Andy Berglund, director of the University at Albany's RNA Institute, discusses the symptoms, prevalence and current research surrounding Myotonic Distrophy with the Engagement Ring podcast.
RNA Institute Awarded $2.5M from NIH to Advance ‘RNA Rescue’ in Fight Against Myotonic Dystrophy
The grant will be used to advance research aimed at finding a cure for the most common form of adult-onset muscular dystrophy, which impacts about 1 in 2,100 New Yorkers.